61 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Antiviral
  • Mineral Supplement
  • North America
  • United States
  • Market Size
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Antiviral
  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • Antiviral
  • Mineral Supplement
  • East Asia
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.

Oxford University Press, ## Suppl ##(Suppl ##), pp.

  • Antiviral
  • Japan
  • United States
  • Atara Biotherapeutics, Inc.
  • Moderna Therapeutics, Inc.

Genotype ## is the most common HCV.

  • Antiviral
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group

Develops drugs for the treatment of inflammatory and gastrointestinal diseases.

  • Antiviral
  • China
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Vendor landscape

China has about one fertility center for every ##. ## million individuals, while the US has one center for every ##, ## individuals.

  • Antiviral
  • United States
  • Demographic
  • Ferring International Center S.A.
  • Merck & Co., Inc.

You can easily book an appointment with one online.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Ferring International Center S.A.
  • Merck & Co., Inc.
  • Other prominent vendors

A single cause in one of the partners or a combination of factors, either in one or both partners, can lead to infertility.

  • Antiviral
  • United States
  • CooperSurgical, Inc.
  • Merck & Co., Inc.
  • Monash IVF Group Limited

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Antiviral
  • Mineral Supplement
  • North America
  • United States
  • Demand

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.

HIV

4385 5000 3900
  • Reyataz pivotal trial data in HIV-1 infection
  • Reyataz late-phase trial data in HIV-1 infection

Gastrointestinal (GI) toxicities were documented in a similar percentage of patients in the Tybost (##. ##%) and Norvir (##. ##%) treatment arms.

  • Antiviral
  • Europe
  • European Union
  • North America
  • United States

Elvitegravir inhibits HIV-## integrase.

  • Antiviral
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc

References P##(SHC) Therapeutic Area/ Disease Indications Diabetes Gastrointestinal lesions University of Bari Aldo Moro, Italy.

  • Antiviral
  • Insulin
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • Clinical Trial profile. 187 Trial Title
  • Clinical Trial profile. 341 Trial Title

The prominent features of this report are - ##.

  • Antiviral
  • Cytokine
  • Mineral Supplement
  • Pharmaceutical
  • World

THE MOLECULES THAT BLOCK PD-## PATHWAY INHIBIT THE INTERACTION BETWEEN PD- ## AND ITS LIGANDS (PDL-## AND PDL-##).

  • Antiviral
  • North America
  • United States
  • Incyte Corporation
  • Merck & Co., Inc.
  • Hetero Drugs Ltd, Deals By Therapy Area, 2012 to YTD 2018
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • Antiviral
  • Mineral Supplement
  • Pharmaceutical
  • India
  • Hetero Drugs Limited

Preclinical studies have shown the potential of ABX## in oncology, in particular in HCC and in turning melanomas not responsive to anti-PD-## (cold) to tumors responsive to anti-PD-## (hot).

  • Antiviral
  • HIV AIDS
  • France
  • Company
  • ABIVAX
  • Medivir AB, Deals By Therapy Area, 2012 to YTD 2018

This agreement enables Beactica to advance one of their prioritized discovery programmes and enables Medivir to search for hits active against one of its early discovery targets.

  • Antiviral
  • Healthcare
  • Pharmaceutical
  • Sweden
  • Medivir UK Ltd.

Deal Rationale Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases.

  • Antiviral
  • Pharmaceutical
  • United States
  • Company
  • ContraVir Pharmaceuticals, Inc.
  • ACYCLOVIR SWOT ANALYSIS, 2014

VALACYCLOVIR IS AVAILABLE FOR ORAL ADMINISTRATION AND HAS THREE- TO FIVE- FOLD HIGHER BIOAVAILABILITY THAN ORAL ACYCLOVIR DUE TO ITS BETTER ABSORPTION BY THE HUMAN GASTROINTESTINAL TRACT (SOUL-LAWTON ET AL., 1995).

  • Antiviral
  • Mineral Supplement
  • United States
  • Forecast
  • Genocea Biosciences, Inc.

The estimated cost of the Phase II trial is under $## million.

  • Antiviral
  • Pharmaceutical
  • Therapy
  • United States
  • Can-Fite BioPharma Ltd.
  • BRINCIDOFOVIR - DRUG PROFILE

Gastrointestinal (GI) side effects were absent.

  • Antiviral
  • Therapy
  • United States
  • Product Initiative
  • Chimerix, Inc.